Please login to the form below

Not currently logged in
Email:
Password:

US obesity levels soar

Healthcare spending on obesity rose 82 per cent to $303bn in five years from 2001 to 2006

US healthcare spending on obesity soared in the five years from 2001 – 2006, according to figures from a government report, with expenditure rising 82 per cent to $303bn.

Healthcare costs for overweight people rose 36 per cent to $275bn in the period, while spending on healthy-weight individuals increased by 25 per cent to $260bn.

Obese people accounted for 28 per cent of healthcare spending in 2001, this climbed to 35 per cent in 2006, while expenditure for healthy-weight people fell from 35 per cent in 2001 to 30 per cent in 2006.

Between 2001 and 2006, the number of obese adults in the US rose to 59 million from 48 million. The number of healthy-weight people fell from 79.6 million to 78.3 million, according to figures from the Medical Expenditure Panel Survey.

According to the report, 59.7 per cent of the US population is obese – in most cases obese individuals have a least one chronic disease, such as diabetes or heart disease, putting a further strain on healthcare spending.

20th August 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics